George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Feb 2012 07:00

RNS Number : 5149X
Intercede Group PLC
16 February 2012
 



16 February 2012

Intercede Group plc

("Intercede")

 

Trading Update

 

Intercede reports that the financial year ending 31 March 2012 will be profitable and cash generating. However, with six weeks to go before the end of the period, the order book of £6.3m stands at a similar position to the prior year. The Company's ability to book further orders before 31 March is dependent on a small number of projects in the pipeline receiving customer approval in sufficient time for deliveries to be made and revenue recognised.

In a challenging global economy, customers are moving to rental models that defer revenue recognition into future periods (with the potential to generate much higher medium term shareholder value from greater earnings visibility) and/or deferring project start dates. A number of large prospects have transitioned within the last six months from wishing to buy perpetual software licenses to specifying rental models, driven by market trends for Software as a Service (SaaS),at the expense of reducing current year revenue expectations. We continue to invest for growth as ID and Credentials Management remains a key priority for governments and enterprise. We see a continuing global pipeline of opportunities, which may be delayed, but not cancelled.

As at 10 February 2012 cash balances totalled £7.0m up from £6.6m reported on 30 September 2011.

Richard Parris, Intercede Chairman & Chief Executive, said:

"Whilst it is disappointing that short term revenues do not reflect the significant strategic and commercial progress made by Intercede, we nevertheless believe the business is in a better position to generate long term shareholder value. We are continuing to work to address any revenue gap in the current year but we are dependent on the buying behaviour of large government and corporate customers.

"In the period we have invested according to plan to reinforce our positioning with major partners such as Microsoft, extended our product reach into the smart phone market and are poised to participate in a number of high volume managed service projects.

"To fully exploit the growth opportunity we have created, Intercede has also appointed an international sales director, increased our marketing expenditure, invested in a new website, engaged with UKTI to drive export sales into new markets and extended our US office.

"We will issue a further update on trading in early April."

###

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. + 44 (0)20 7220 0500

Sarah Wharry

Rose Herbert

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Clare Gilbey

 

About Intercede

Intercede is the producer of the MyID® identity and credential management system (IDCMS), the MyID Management Agent for Microsoft® Forefront™ Identity Manager and a range of mobile applications for securing smartphones.

The company's website has recently been re-launched to better reflect its enhanced proposition. For more information visit www.intercede.com, email info@intercede.com or call +44 (0)1455 558111.

MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 340,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, MyID is being deployed in support of government identity, financial services, healthcare and corporate employee ID security projects.

MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people, secure devices and their associated credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card and smartphone personalization, issuance and management.

At the forefront of the secure identity field, Intercede also offers innovative new solutions for smartphones, including secure email, physical and logical access, identity verification via near field communications and attribute management. With the trend towards 'bring your own device' in the workplace and the move to cloud-based services, MyID allows organizations to embrace new and more convenient approaches to security.

MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible (CIV) deployments.

MyID provides customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFWIFESEIE
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.